Equillium (EQ) Current Taxes (2017 - 2025)

Equillium (EQ) posted quarterly Current Taxes of $17000.0 for Q3 2025, little changed quarter-over-quarter from $17000.0 in Q2 2025.

Analysis

Equillium (EQ) Current Taxes (2017 - 2025) Analysis & Trends

Equillium (EQ) has reported Current Taxes for 4 consecutive years, with $17000.0 the latest figure, recorded in Q3 2025.

In Q3 2025, Current Taxes changed N/A year-over-year to $17000.0; the TTM figure through Sep 2025 stood at $17000.0 (changed N/A YoY), while the FY2024 annual figure was $365000.0, changed N/A from the prior year.
Current Taxes steadied at $17000.0 in Q3 2025 per EQ's latest filing, from $17000.0 in the prior quarter.
Across five years, Current Taxes topped out at $564000.0 in Q3 2023 and bottomed at $17000.0 in Q2 2025.
Historically, Current Taxes has averaged $265600.0 across 3 years, with a median of $365000.0 in 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	49.00 Mn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	76.32 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Equillium	249.33 Mn	249.33 Mn	-	-

Historic Data

Download Data